ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects

ClinicalTrials.gov ID: NCT00634283

Public ClinicalTrials.gov record NCT00634283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Physiologic Monitoring of Antidepressant Medication Effects in Normal Healthy Subjects II

Study identification

NCT ID
NCT00634283
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
University of California, Los Angeles
Other
Enrollment
6 participants

Conditions and interventions

Conditions

Interventions

  • venlafaxine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jan 31, 2009
Completion
Jan 31, 2009
Last update posted
Mar 8, 2020

2008 – 2009

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of California Los Angeles (UCLA) Los Angeles California 90024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00634283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2020 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00634283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →